CG Oncology, Inc. announces positive results from its Phase 3 PIVOT-006 trial, showing improved outcomes for bladder cancer patients.
| Name | CG Oncology, Inc. |
|---|---|
| CIK | 0001991792 |
| Tickers | CGON |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 371611499 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (949) 409-3700 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
CG Oncology, Inc. announces positive results from its Phase 3 PIVOT-006 trial, showing improved outcomes for bladder cancer patients.
CG Oncology, Inc. releases its Q3 results, detailing progress in its biological products segment and addressing market challenges in the industry.
CG Oncology, Inc. announces third-quarter financial results, showcasing strong cash reserves and upcoming clinical trial data that could impact the biological products industry.
CG Oncology, Inc. announces Isabel Kalofonos as its new Chief Commercial Officer, marking a significant leadership change in the biological products sector.
249 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 4 | 4 | 0001193125-26-467162 | 4582 | ||||||
| 2026-11-18 | 4 | 4 | 0001193125-26-467159 | 4934 | ||||||
| 2026-11-17 | 4 | 4 | 0001193125-26-465593 | 8220 | ||||||
| 2026-11-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-462199 | 001-41925 | 261555609 | 34 | 17742120 | 1 | 1 |
| 2026-11-06 | 10-Q | 10-Q | 0001991792-26-000012 | 001-41925 | 261529554 | 34 | 5813924 | 1 | 1 | |
| 2026-11-06 | 8-K | 8-K | 2.02,9.01 | 0001991792-26-000011 | 001-41925 | 261529497 | 34 | 266813 | 1 | 1 |
| 2026-10-19 | 4 | 4 | 0001193125-26-425297 | 5735 | ||||||
| 2026-10-19 | 4 | 4 | 0001193125-26-425295 | 10608 | ||||||
| 2026-10-19 | 3 | 3 | 0001193125-26-425256 | 13861 | ||||||
| 2026-10-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010274 | 001-41925 | 261463492 | 33 | 6449 | |||
| 2026-09-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009691 | 001-41925 | 261393857 | 33 | 21294 | |||
| 2026-09-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009639 | 001-41925 | 261387312 | 33 | 20540 | |||
| 2026-09-17 | 4 | 4 | 0001193125-26-394394 | 8712 | ||||||
| 2026-09-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009375 | 001-41925 | 261375186 | 33 | 19788 | |||
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009036 | 001-41925 | 261355799 | 33 | 19041 | |||
| 2026-08-31 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008873 | 001-41925 | 261347280 | 33 | 18288 | |||
| 2026-08-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008793 | 001-41925 | 261331677 | 33 | 17534 | |||
| 2026-08-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008678 | 001-41925 | 261316332 | 33 | 16784 | |||
| 2026-08-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008634 | 001-41925 | 261311548 | 33 | 16031 | |||
| 2026-08-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008371 | 001-41925 | 261295199 | 33 | 15860 | |||
| 2026-08-18 | 4 | 4 | 0001193125-26-355561 | 8217 | ||||||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008205 | 001-41925 | 261286753 | 33 | 14527 | |||
| 2026-08-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008191 | 001-41925 | 261284245 | 33 | 13774 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097055 | 005-94327 | 261280914 | 34 | 23359 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000147 | 005-94327 | 261276159 | 34 | 10379 | |||
| 2026-08-13 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008109 | 001-41925 | 261274801 | 33 | 13021 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000242 | 005-94327 | 261273149 | 34 | 17335 | |||
| 2026-08-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008043 | 001-41925 | 261269018 | 33 | 12268 | |||
| 2026-08-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007989 | 001-41925 | 261264747 | 33 | 11515 | |||
| 2026-08-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007845 | 001-41925 | 261258299 | 33 | 10762 | |||
| 2026-08-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007823 | 001-41925 | 261254953 | 33 | 10008 | |||
| 2026-08-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007736 | 001-41925 | 261249340 | 33 | 9258 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-336918 | 001-41925 | 261246400 | 34 | 8941303 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-336886 | 001-41925 | 261246229 | 34 | 564245 | 1 | 1 |
| 2026-08-06 | 424B5 | 424B5 | 0001193125-26-336792 | 333-286230 | 261246099 | 33 | 309801 | 1 | 1 | |
| 2026-08-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007711 | 001-41925 | 261244178 | 33 | 8505 | |||
| 2026-07-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007416 | 001-41925 | 261218064 | 33 | 7751 | |||
| 2026-07-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007370 | 001-41925 | 261212772 | 33 | 7001 | |||
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002283 | 005-94327 | 261206145 | 34 | 11125 | |||
| 2026-07-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007310 | 001-41925 | 261205669 | 33 | 6248 | |||
| 2026-07-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007270 | 001-41925 | 261196992 | 33 | 5495 | |||
| 2026-07-17 | 4 | 4 | 0001193125-26-307838 | 8217 | ||||||
| 2026-07-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007109 | 001-41925 | 261177645 | 33 | 4742 | |||
| 2026-07-14 | 4 | 4 | 0001193125-26-303188 | 8722 | ||||||
| 2026-07-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007021 | 001-41925 | 261169183 | 33 | 6233 | |||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006790 | 001-41925 | 261146364 | 33 | 6228 | |||
| 2026-06-29 | 4 | FORM 4 | 0001140361-26-026779 | 5149 | ||||||
| 2026-06-25 | 4 | 4 | 0001193125-26-282861 | 8214 | ||||||
| 2026-06-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006467 | 001-41925 | 261116409 | 33 | 6456 | |||
| 2026-06-23 | 4 | 4 | 0001193125-26-279543 | 8214 | ||||||
| 2026-06-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006393 | 001-41925 | 261107797 | 33 | 5737 | |||
| 2026-06-16 | 4 | xslF345X06/form4-06162026_090604.xml | 0001684531-26-000002 | 13926 | ||||||
| 2026-06-08 | 8-K | 8-K | 5.07 | 0001193125-26-261670 | 001-41925 | 261072523 | 34 | 150454 | 1 | 1 |
| 2026-06-05 | 4 | 4 | 0001193125-26-259700 | 5740 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259693 | 5745 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259691 | 5716 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259705 | 10848 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259690 | 5714 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259688 | 5691 | ||||||
| 2026-06-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005645 | 001-41925 | 261065377 | 33 | 5017 | |||
| 2026-05-26 | 8-K | 8-K | 5.02 | 0001193125-26-237908 | 001-41925 | 261015969 | 34 | 156539 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000502 | 005-94327 | 26983407 | 34 | 7566 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000102 | 005-94327 | 26982483 | 34 | 12582 | |||
| 2026-05-08 | 10-Q | 10-Q | 0001193125-26-214669 | 001-41925 | 26958557 | 34 | 7793261 | 1 | 1 | |
| 2026-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-213440 | 001-41925 | 26956230 | 34 | 348916 | 1 | 1 |
| 2026-04-24 | ARS | ARS | 0001193125-26-177430 | 001-41925 | 26894829 | 34 | 5107637 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001193125-26-177424 | 001-41925 | 26894803 | 34 | 1898633 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001193125-26-177395 | 001-41925 | 26894755 | 34 | 5698553 | 1 | 1 | |
| 2026-04-20 | 4 | 4 | 0001193125-26-164013 | 8722 | ||||||
| 2026-04-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003597 | 001-41925 | 26872073 | 33 | 5741 | |||
| 2026-04-16 | 4 | 4 | 0001193125-26-159031 | 5507 | ||||||
| 2026-04-16 | 4 | 4 | 0001193125-26-159030 | 5508 | ||||||
| 2026-04-16 | 4 | 4 | 0001193125-26-159029 | 5526 | ||||||
| 2026-04-16 | 4 | 4 | 0001193125-26-159025 | 5576 | ||||||
| 2026-04-16 | 4 | 4 | 0001193125-26-159024 | 5506 | ||||||
| 2026-04-13 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-152044 | 001-41925 | 26856536 | 34 | 450980 | 1 | 1 |
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000918 | 005-94327 | 26799328 | 34 | 7185 | |||
| 2026-03-17 | 4 | 4 | 0001193125-26-110831 | 13084 | ||||||
| 2026-03-13 | 4 | xslF345X05/form4-03132026_080321.xml | 0002007101-26-000004 | 8862 | ||||||
| 2026-03-06 | 4 | xslF345X05/form4-03062026_100310.xml | 0002007101-26-000002 | 8871 | ||||||
| 2026-02-27 | S-8 | S-8 | 0001193125-26-079539 | 333-293839 | 26693076 | 33 | 530006 | 1 | 1 | |
| 2026-02-27 | 10-K | 10-K | 0001193125-26-079498 | 001-41925 | 26693016 | 34 | 24791355 | 1 | 1 | |
| 2026-02-27 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-079452 | 001-41925 | 26692925 | 34 | 348786 | 1 | 1 |
| 2026-01-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-011855 | 001-41925 | 26530654 | 34 | 160290 | 1 | 1 |
| 2026-01-13 | 424B5 | 424B5 | 0001193125-26-011846 | 333-286230 | 26530628 | 33 | 285425 | 1 | 1 | |
| 2026-01-13 | 4 | 4 | 0001193125-26-011756 | 13097 | ||||||
| 2026-01-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000305 | 001-41925 | 26523453 | 33 | 5032 | |||
| 2026-01-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-008329 | 001-41925 | 26521428 | 34 | 15949083 | 1 | 1 |
| 2025-11-26 | 4 | 4 | 0001193125-25-300645 | 5312 | ||||||
| 2025-11-26 | 3 | 3 | 0001193125-25-300536 | 19222 | ||||||
| 2025-11-26 | 8-K | 8-K | 5.02 | 0001193125-25-298160 | 001-41925 | 251523836 | 34 | 162423 | 1 | 1 |
| 2025-11-24 | 3 | 3 | 0001193125-25-293740 | 13540 | ||||||
| 2025-11-18 | 4 | 4 | 0001193125-25-286228 | 8090 | ||||||
| 2025-11-14 | 8-K | 8-K | 5.02 | 0001193125-25-283108 | 001-41925 | 251487103 | 34 | 163962 | 1 | 1 |
| 2025-11-14 | 10-Q | 10-Q | 0001193125-25-283000 | 001-41925 | 251486480 | 34 | 9981630 | 1 | 1 | |
| 2025-11-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-281672 | 001-41925 | 251481384 | 34 | 405762 | 1 | 1 |
| 2025-11-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000430 | 005-94327 | 251469857 | 34 | 17096 | |||
| 2025-10-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-25-000082 | 005-94327 | 251434564 | 34 | 6231 | |||
| 2025-10-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001013594-25-001271 | 005-94327 | 251425815 | 34 | 28473 | |||
| 2025-10-15 | 4 | 4 | 0001193125-25-240271 | 8090 | ||||||
| 2025-10-10 | 4 | 4 | 0001193125-25-237104 | 8174 | ||||||
| 2025-10-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007869 | 001-41925 | 251385294 | 33 | 7921 | |||
| 2025-10-01 | 4 | 4 | 0001193125-25-226964 | 8588 | ||||||
| 2025-09-30 | 4 | 4 | 0001193125-25-225133 | 8589 | ||||||
| 2025-09-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007578 | 001-41925 | 251360869 | 33 | 7195 | |||
| 2025-09-22 | 4 | 4 | 0001193125-25-210015 | 13378 | ||||||
| 2025-09-18 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-25-207734 | 005-94327 | 251324742 | 34 | 133724 | |||
| 2025-09-18 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001013594-25-001163 | 005-94327 | 251324704 | 34 | 22506 | |||
| 2025-09-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007326 | 001-41925 | 251323801 | 33 | 5752 | |||
| 2025-09-16 | 4 | 4 | 0001193125-25-205003 | 8089 | ||||||
| 2025-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007139 | 001-41925 | 251314706 | 33 | 6471 | |||
| 2025-09-15 | 4 | 4 | 0001193125-25-202873 | 5152 | ||||||
| 2025-09-09 | 8-K | 8-K | 7.01,9.01 | 0001991792-25-000007 | 001-41925 | 251301636 | 34 | 19648073 | 1 | 1 |
| 2025-09-08 | 4 | 4 | 0000950170-25-113556 | 14295 | ||||||
| 2025-09-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006800 | 001-41925 | 251297043 | 33 | 4794 | |||
| 2025-09-05 | 8-K | 8-K | 7.01,8.01,9.01 | 0001991792-25-000004 | 001-41925 | 251294996 | 34 | 259867 | 1 | 1 |
| 2025-09-04 | 4 | 4 | 0002008157-25-000004 | 12757 | ||||||
| 2025-09-04 | 4 | 4 | 0001235862-25-000003 | 8087 | ||||||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001961863-25-000140 | 001-41925 | 251290846 | 33 | 4560 | |||
| 2025-09-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006716 | 001-41925 | 251290164 | 33 | 5516 | |||
| 2025-08-08 | 10-Q | 10-Q | 0000950170-25-105855 | 001-41925 | 251198614 | 34 | 7723868 | 1 | 1 | |
| 2025-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-105487 | 001-41925 | 251196278 | 34 | 386236 | 1 | 1 |
| 2025-08-06 | 3 | 3 | 0000950170-25-104053 | 23023 | ||||||
| 2025-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002004 | 005-94327 | 251188302 | 34 | 10932 | |||
| 2025-07-18 | 4 | 4 | 0000950170-25-096949 | 8087 | ||||||
| 2025-07-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-005089 | 001-41925 | 251130893 | 33 | 6240 | |||
| 2025-07-11 | 8-K | 8-K | 5.02 | 0000950170-25-095296 | 001-41925 | 251119159 | 34 | 162258 | 1 | 1 |
| 2025-06-06 | 4 | 4 | 0000950170-25-083235 | 5562 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083240 | 5583 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083239 | 5593 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083238 | 5583 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083237 | 5611 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083236 | 5616 | ||||||
| 2025-06-06 | 8-K | 8-K | 5.07 | 0000950170-25-083088 | 001-41925 | 251030847 | 34 | 179639 | 1 | 1 |
| 2025-05-22 | 4 | 4 | 0000950170-25-076339 | 8086 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-072759 | 005-94327 | 25954226 | 34 | 13286 | |||
| 2025-05-13 | 10-Q | 10-Q | 0000950170-25-069831 | 001-41925 | 25937347 | 34 | 6782734 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-069825 | 001-41925 | 25937284 | 34 | 419278 | 1 | 1 |
| 2025-04-29 | 4 | 4 | 0000950170-25-060145 | 8089 | ||||||
| 2025-04-28 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-058956 | 001-41925 | 25875947 | 34 | 272075 | 1 | 1 |
| 2025-04-25 | ARS | ARS | 0000950170-25-058345 | 001-41925 | 25870077 | 34 | 5276157 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0000950170-25-058344 | 001-41925 | 25870068 | 34 | 1886243 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0000950170-25-058342 | 001-41925 | 25870055 | 34 | 3968569 | 1 | 1 | |
| 2025-04-16 | 4 | 4 | 0000950170-25-054742 | 5372 | ||||||
| 2025-04-16 | 4 | 4 | 0000950170-25-054740 | 5373 | ||||||
| 2025-04-16 | 4 | 4 | 0000950170-25-054739 | 5377 | ||||||
| 2025-04-16 | 4 | 4 | 0000950170-25-054738 | 5395 | ||||||
| 2025-04-16 | 4 | 4 | 0000950170-25-054737 | 5353 | ||||||
| 2025-03-28 | S-3ASR | S-3ASR | 0001193125-25-067207 | 333-286230 | 25787364 | 33 | 1335390 | |||
| 2025-03-28 | 10-K | 10-K | 0000950170-25-046351 | 001-41925 | 25781752 | 34 | 28310745 | 1 | 1 | |
| 2025-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-046335 | 001-41925 | 25781463 | 34 | 435848 | 1 | 1 |
| 2025-03-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-043497 | 001-41925 | 25762325 | 34 | 255182 | 1 | 1 |
| 2025-03-18 | 4 | 4 | 0000950170-25-041265 | 8093 | ||||||
| 2025-03-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-001969 | 001-41925 | 25745121 | 33 | 6477 | |||
| 2025-02-19 | 4 | 4 | 0000950170-25-023182 | 8096 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-004201 | 005-94327 | 25631347 | 34 | 19548 | |||
| 2025-01-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-009941 | 005-94327 | 25565469 | 34 | 25469 | |||
| 2025-01-14 | 4 | 4 | 0000950170-25-005359 | 8096 | ||||||
| 2025-01-10 | 8-K | 8-K | 5.02 | 0000950170-25-004168 | 001-41925 | 25523163 | 34 | 171294 | 1 | 1 |
| 2024-12-17 | 4 | xslF345X05/form4-12172024_111213.xml | 0001415889-24-029664 | 7470 | ||||||
| 2024-12-17 | 4 | 4 | 0000950170-24-137319 | 8074 | ||||||
| 2024-12-13 | 424B4 | 424B4 | 0001193125-24-278472 | 333-283725 | 241548392 | 33 | 1130104 | |||
| 2024-12-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-12-12 16:00:00 | 9999999995-24-003769 | 333-283725 | 241546608 | 33 | 1780 | ||
| 2024-12-11 | S-1/A | S-1/A | 0001193125-24-275552 | 333-283725 | 241541608 | 33 | 338954 | |||
| 2024-12-11 | CORRESP | filename1.htm | 0001193125-24-274853 | 12741 | ||||||
| 2024-12-11 | CORRESP | filename1.htm | 0001193125-24-274852 | 8299 | ||||||
| 2024-12-11 | S-1 | S-1 | 0001193125-24-274822 | 333-283725 | 241540038 | 33 | 1249316 | |||
| 2024-12-06 | 4 | 4 | 0000950170-24-134261 | 10150 | ||||||
| 2024-12-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009508 | 001-41925 | 241532747 | 33 | 5030 | |||
| 2024-12-05 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-271116 | 001-41925 | 241527855 | 34 | 197007 | 1 | 1 |
| 2024-11-21 | UPLOAD | filename1.pdf | 0000000000-24-012911 | 377-07557 | 40091 | |||||
| 2024-11-14 | DRS | filename1.htm | 0000950123-24-011900 | 377-07557 | 241464261 | 33 | 515213 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__CGoncology.txt | 0000932471-24-000976 | 005-94327 | 241446999 | 34 | 6573 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-124642 | 001-41925 | 241443657 | 34 | 6653151 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-124636 | 001-41925 | 241443613 | 34 | 215713 | 1 | 1 |
| 2024-11-08 | SC 13G | us1569441009_110824.txt | 0002012383-24-003527 | 005-94327 | 241439658 | 34 | 13786 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CGoncology.txt | 0000932471-24-000211 | 005-94327 | 241421215 | 34 | 5638 | |||
| 2024-10-22 | SC 13G | us1569441009_102224.txt | 0002012383-24-001588 | 005-94327 | 241387307 | 34 | 13774 | |||
| 2024-10-08 | 4 | 4 | 0000950170-24-113418 | 5353 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113320 | 5327 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113314 | 5304 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113311 | 5344 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113310 | 5353 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113308 | 5380 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113304 | 5347 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113299 | 5328 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113297 | 5376 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113290 | 5395 | ||||||
| 2024-10-07 | 4 | 4 | 0000950170-24-113282 | 5375 | ||||||
| 2024-08-30 | 4 | 4 | 0000950170-24-102496 | 7771 | ||||||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0001961863-24-000310 | 001-41925 | 241265509 | 33 | 4613 | |||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0001961863-24-000309 | 001-41925 | 241265503 | 33 | 4585 | |||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0001961863-24-000308 | 001-41925 | 241265294 | 33 | 4613 | |||
| 2024-08-29 | 144 | xsl144X01/primary_doc.xml | 0001961863-24-000307 | 001-41925 | 241265289 | 33 | 4585 | |||
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-093238 | 001-41925 | 241185867 | 34 | 6212286 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093237 | 001-41925 | 241185866 | 34 | 227707 | 1 | 1 |
| 2024-07-22 | SC 13G | SC 13G | 0001193125-24-182242 | 005-94327 | 241131926 | 34 | 199578 | |||
| 2024-05-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-064309 | 001-41925 | 24980887 | 34 | 236942 | 1 | 1 |
| 2024-05-16 | 4 | 4 | 0000950170-24-061276 | 5374 | ||||||
| 2024-05-16 | 3 | 3 | 0000950170-24-061188 | 24091 | ||||||
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-134805 | 001-41925 | 24928707 | 34 | 184146 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-056196 | 001-41925 | 24928358 | 34 | 5457319 | 1 | 1 | |
| 2024-05-03 | 8-K | 8-K | 8.01 | 0001193125-24-130800 | 001-41925 | 24913710 | 34 | 154788 | 1 | 1 |
| 2024-04-09 | SC 13G/A | SC 13G/A | 0001104659-24-045323 | 005-94327 | 24833884 | 34 | 112991 | |||
| 2024-04-09 | 4/A | xslF345X05/form4a-04092024_110416.xml | 0001415889-24-010609 | 13014 | ||||||
| 2024-03-26 | 10-K | 10-K | 0000950170-24-036143 | 001-41925 | 24780831 | 34 | 14687372 | |||
| 2024-03-14 | SC 13G | SC 13G | 0001193125-24-068189 | 005-94327 | 24751986 | 34 | 44399 | |||
| 2024-02-16 | 8-K | 8-K | 5.02 | 0001193125-24-038506 | 001-41925 | 24648680 | 34 | 169278 | 1 | 1 |
| 2024-02-09 | SC 13G | SC 13G | 0001193125-24-030117 | 005-94327 | 24615530 | 34 | 73915 | |||
| 2024-02-08 | SC 13G | SC 13G | 0001104659-24-012374 | 005-94327 | 24610183 | 34 | 113361 | |||
| 2024-02-05 | SC 13G | SC 13G | 0001193125-24-024118 | 005-94327 | 24596355 | 34 | 122533 | |||
| 2024-02-05 | SC 13G | SC 13G | 0001104659-24-010557 | 005-94327 | 24595430 | 34 | 125264 | |||
| 2024-01-31 | 4 | 4 | 0000950170-24-009435 | 4450 | ||||||
| 2024-01-31 | 4 | 4 | 0000950170-24-009432 | 4406 | ||||||
| 2024-01-31 | 4 | 4 | 0000950170-24-009429 | 19023 | ||||||
| 2024-01-31 | 4 | xslF345X05/form4-01312024_090105.xml | 0001415889-24-002062 | 21672 | ||||||
| 2024-01-30 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-24-018715 | 001-41925 | 24575798 | 34 | 422415 | 1 | 1 |
| 2024-01-26 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-000220 | 63507 | ||||||
| 2024-01-26 | S-8 | S-8 | 0001193125-24-016881 | 333-276729 | 24569188 | 33 | 969052 | |||
| 2024-01-26 | 4 | 4 | 0000950170-24-007962 | 5295 | ||||||
| 2024-01-25 | 424B4 | 424B4 | 0001193125-24-015534 | 333-276350 | 24563151 | 33 | 4548674 | |||
| 2024-01-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-01-24 16:00:00 | 9999999995-24-000197 | 333-276350 | 24558442 | 33 | 1779 | ||
| 2024-01-24 | 3 | 3 | 0000950170-24-007178 | 21467 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007176 | 27308 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007173 | 27386 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007171 | 22312 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007170 | 41750 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007167 | 23798 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007166 | 23934 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007164 | 22391 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007163 | 21247 | ||||||
| 2024-01-24 | 3 | 3 | 0000950170-24-007157 | 26847 | ||||||
| 2024-01-24 | 3 | xslF345X02/form3-01252024_010140.xml | 0001415889-24-001783 | 12042 | ||||||
| 2024-01-24 | S-1MEF | S-1MEF | 0001193125-24-014437 | 333-276685 | 24558210 | 33 | 48774 | |||
| 2024-01-24 | CERT | 8A_Cert_IPO_CGON.pdf | 0001354457-24-000028 | 001-41925 | 24554535 | 34 | 251889 | |||
| 2024-01-23 | S-1/A | S-1/A | 0001193125-24-012523 | 333-276350 | 24550428 | 33 | 4669349 | |||
| 2024-01-22 | CORRESP | filename1.htm | 0001193125-24-012244 | 8799 | ||||||
| 2024-01-22 | CORRESP | filename1.htm | 0001193125-24-012237 | 7763 | ||||||
| 2024-01-22 | 8-A12B | 8-A12B | 0001193125-24-012233 | 001-41925 | 24549513 | 34 | 13875 | |||
| 2024-01-18 | S-1/A | S-1/A | 0001193125-24-009621 | 333-276350 | 24540053 | 33 | 6382844 | |||
| 2024-01-05 | CORRESP | filename1.htm | 0001193125-24-002809 | 138518 | ||||||
| 2024-01-02 | CORRESP | filename1.htm | 0001193125-24-000774 | 32793 | ||||||
| 2024-01-02 | S-1 | S-1 | 0001193125-24-000766 | 333-276350 | 24503477 | 33 | 7750563 | |||
| 2023-12-18 | UPLOAD | filename1.pdf | 0000000000-23-013792 | 377-06934 | 46607 | |||||
| 2023-12-04 | DRSLTR | filename1.htm | 0000950123-23-011117 | 40148 | ||||||
| 2023-12-04 | DRS/A | filename1.htm | 0000950123-23-011116 | 377-06934 | 231464216 | 33 | 4659747 | |||
| 2023-11-27 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-000249 | 64463 | ||||||
| 2023-11-27 | UPLOAD | filename1.pdf | 0000000000-23-012841 | 377-06934 | 52226 | |||||
| 2023-10-27 | DRS | filename1.htm | 0000950123-23-009093 | 377-06934 | 231356058 | 33 | 6051117 |
One latest value per concept from companyfacts (228 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 89.32M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.70B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.73M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177395 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.33M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177395 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 131.07 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177395 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 28.62M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177395 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 11.93M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177395 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 111.7 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177395 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 69,050 | 2026-08-06 | 424B5 | 2026-08-06 | 0001193125-26-336792 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 1.05B | 2026-08-06 | 424B5 | 2026-08-06 | 0001193125-26-336792 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 148,755 | 2026-08-06 | 424B5 | 2026-08-06 | 0001193125-26-336792 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 1.05B | 2026-08-06 | 424B5 | 2026-08-06 | 0001193125-26-336792 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-06 | 424B5 | 2026-08-06 | 0001193125-26-336792 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 79,705 | 2026-08-06 | 424B5 | 2026-08-06 | 0001193125-26-336792 | |||
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 562,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 11.33M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124642 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 9.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 7.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 35.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 2.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 3.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.57B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 8.46M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 29.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 7.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | Assets | Assets | USD | 1.05B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.01B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities | USD | 307,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CapitalizedComputerSoftwareNet | Capitalized Computer Software, Net | USD | 1.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 28.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 21.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 28.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -4.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 15.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 700.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 89.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 89.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 9,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -196.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 29,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 9.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 8,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 8,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | DebtInstrumentFeeAmount | Debt Instrument, Fee Amount | USD | 400,000 | 2024-03-05 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124642 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0000950170-25-046351 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -261,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -278,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 2.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 400,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -17,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | DeferredTaxAssetInterestCarryforward | Deferred Tax Asset, Interest Carryforward | USD | 1.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 95.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 9.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 93.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 64.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 301.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 292.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 11.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 9.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 523,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 425,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 4.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 93.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 30,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 248,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 1.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | Depreciation | Depreciation | USD | 2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.223 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.026 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.062 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0000950170-25-046351 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 25,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 275,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 60,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 43,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001193125-25-283000 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 60,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 60,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 60,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 60,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 600,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 530,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 72.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | Goodwill | Goodwill | USD | 10.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncomeTaxExaminationInterestAccrued | Income Tax Examination, Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | IncomeTaxExaminationPenaltiesAccrued | Income Tax Examination, Penalties Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | IncomeTaxExaminationPenaltiesExpense | Income Tax Examination, Penalties Expense | USD | 0 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -270,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 16,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 35.88M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -33.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 315,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -88,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -71,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.94M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | -219,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 4.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -22,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -4.13M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0000950170-24-056196 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 11.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -978,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 5.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 6.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 142,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | InventoryNet | Inventory, Net | USD | 1.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 20.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 1.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 7.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 164,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 470,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | Liabilities | Liabilities | USD | 55.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.05B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 46.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 3.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | LossContingencyDamagesAwardedValue | Loss Contingency, Damages Awarded, Value | USD | 0 | 2025-07-29 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 956.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 405.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -258.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -151.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -196.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -161.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 19.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | NotesAndLoansReceivableNetNoncurrent | Financing Receivable, after Allowance for Credit Loss, Noncurrent | USD | 26.68M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 219.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 91.00M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -216.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 6.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 5.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 926,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.068 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 6.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 855,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | OtherNoncashIncome | Other Noncash Income | USD | 768,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -139,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -150,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 186,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 197,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 783.40M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336918 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 905.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | PaymentsToAcquireNotesReceivable | Payments to Acquire Notes Receivable | USD | 26.00M | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336918 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 529.85M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 |
| us-gaap | PreferredStockConvertibleConversionPrice | PreferredStockConvertibleConversionPrice | USD/shares | 1.33 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0000950170-25-046351 | |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 21.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 406.41M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 391.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 104.63M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 370.52M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105855 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 649.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 14.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -139.26M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336918 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 18.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 14.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 666,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | RedeemablePreferredStockDividends | Redeemable Preferred Stock Dividends | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 137.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -575.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 3.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 3.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 29.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.7 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.63 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.049 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 188.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 17.63 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 468,690 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 35.96 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 43.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 319.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 26.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 3.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 26.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 319.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 7.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 29.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 8.84 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 67.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 990.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.105 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 38.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 1.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 307.89M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 10.28M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | TradingSecuritiesDebt | Debt Securities, Trading | USD | 956.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -9.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 1.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 505,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 1.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 36.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079498 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 87.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 87.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001991792-26-000012 |